An Ocean between the Waves: Trends in Antimicrobial Consumption in Hospitalized Patients with COVID-19

We assessed the antibiotic use in SARS-CoV-2-infected patients during four different waves of the COVID-19 pandemic, as well as its trends over the period and associated risk factors. We performed a cross-sectional retrospective analysis nested in a prospectively collected cohort of hospitalized adu...

Full description

Bibliographic Details
Main Authors: Xavier Durà-Miralles, Gabriela Abelenda-Alonso, Alba Bergas, Júlia Laporte-Amargós, Enric Sastre-Escolà, Ariadna Padullés, Jordi Carratalà, Carlota Gudiol
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/13/1/55
_version_ 1797344782516748288
author Xavier Durà-Miralles
Gabriela Abelenda-Alonso
Alba Bergas
Júlia Laporte-Amargós
Enric Sastre-Escolà
Ariadna Padullés
Jordi Carratalà
Carlota Gudiol
author_facet Xavier Durà-Miralles
Gabriela Abelenda-Alonso
Alba Bergas
Júlia Laporte-Amargós
Enric Sastre-Escolà
Ariadna Padullés
Jordi Carratalà
Carlota Gudiol
author_sort Xavier Durà-Miralles
collection DOAJ
description We assessed the antibiotic use in SARS-CoV-2-infected patients during four different waves of the COVID-19 pandemic, as well as its trends over the period and associated risk factors. We performed a cross-sectional retrospective analysis nested in a prospectively collected cohort of hospitalized adult patients with COVID-19 at a university hospital in Spain. A total of 2415 patients were included in this study, among whom 1120 corresponded to the first wave. The highest percentage of patients receiving some sort of antibiotic treatment was higher during the first wave (77.6%) than during the others; nevertheless, our calculation of the average DOT (days of antibiotic treatment) per 100 patient days of stay found that the highest antibiotic prescription rate corresponded to the second pandemic wave (61.61 DOT/100 patient days), which was associated with a higher ICU admission rate and a lower SpO<sub>2</sub>/FiO<sub>2</sub> ratio at admission. After the second wave, the prescription rates presented a steady downward trend. With regard to the use of specific antibiotic families, amoxicillin/clavulanate was the most used antibiotic in our cohort (14.20 DOT/100 patient days) due to a high prescription rate during the first wave. According to the “AWaRe” WHO classification, antibiotics corresponding to the “Watch” group were the most prescribed (27.92 DOT/100 patient days). The antibiotic use rate fell progressively, but it remained high during all four waves analyzed. In conclusion, antibiotic use was high throughout all the waves that were analyzed, despite a relatively low incidence of bacterial coinfection and superinfection. Efforts should be made to keep antimicrobial stewardship programs active, especially in complicated epidemiological situations, such as the SARS-CoV-2 pandemic.
first_indexed 2024-03-08T11:07:54Z
format Article
id doaj.art-e26b1fae564e470fb1f78c3570ae72bd
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-08T11:07:54Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-e26b1fae564e470fb1f78c3570ae72bd2024-01-26T14:37:12ZengMDPI AGAntibiotics2079-63822024-01-011315510.3390/antibiotics13010055An Ocean between the Waves: Trends in Antimicrobial Consumption in Hospitalized Patients with COVID-19Xavier Durà-Miralles0Gabriela Abelenda-Alonso1Alba Bergas2Júlia Laporte-Amargós3Enric Sastre-Escolà4Ariadna Padullés5Jordi Carratalà6Carlota Gudiol7Department of Infectious Diseases, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, SpainDepartment of Infectious Diseases, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, SpainDepartment of Infectious Diseases, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, SpainDepartment of Infectious Diseases, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, SpainDepartment of Infectious Diseases, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, SpainCenter for Biomedical Research in Infectious Diseases Network (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, SpainDepartment of Infectious Diseases, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, SpainDepartment of Infectious Diseases, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, SpainWe assessed the antibiotic use in SARS-CoV-2-infected patients during four different waves of the COVID-19 pandemic, as well as its trends over the period and associated risk factors. We performed a cross-sectional retrospective analysis nested in a prospectively collected cohort of hospitalized adult patients with COVID-19 at a university hospital in Spain. A total of 2415 patients were included in this study, among whom 1120 corresponded to the first wave. The highest percentage of patients receiving some sort of antibiotic treatment was higher during the first wave (77.6%) than during the others; nevertheless, our calculation of the average DOT (days of antibiotic treatment) per 100 patient days of stay found that the highest antibiotic prescription rate corresponded to the second pandemic wave (61.61 DOT/100 patient days), which was associated with a higher ICU admission rate and a lower SpO<sub>2</sub>/FiO<sub>2</sub> ratio at admission. After the second wave, the prescription rates presented a steady downward trend. With regard to the use of specific antibiotic families, amoxicillin/clavulanate was the most used antibiotic in our cohort (14.20 DOT/100 patient days) due to a high prescription rate during the first wave. According to the “AWaRe” WHO classification, antibiotics corresponding to the “Watch” group were the most prescribed (27.92 DOT/100 patient days). The antibiotic use rate fell progressively, but it remained high during all four waves analyzed. In conclusion, antibiotic use was high throughout all the waves that were analyzed, despite a relatively low incidence of bacterial coinfection and superinfection. Efforts should be made to keep antimicrobial stewardship programs active, especially in complicated epidemiological situations, such as the SARS-CoV-2 pandemic.https://www.mdpi.com/2079-6382/13/1/55COVID-19antibioticpandemicstewardship
spellingShingle Xavier Durà-Miralles
Gabriela Abelenda-Alonso
Alba Bergas
Júlia Laporte-Amargós
Enric Sastre-Escolà
Ariadna Padullés
Jordi Carratalà
Carlota Gudiol
An Ocean between the Waves: Trends in Antimicrobial Consumption in Hospitalized Patients with COVID-19
Antibiotics
COVID-19
antibiotic
pandemic
stewardship
title An Ocean between the Waves: Trends in Antimicrobial Consumption in Hospitalized Patients with COVID-19
title_full An Ocean between the Waves: Trends in Antimicrobial Consumption in Hospitalized Patients with COVID-19
title_fullStr An Ocean between the Waves: Trends in Antimicrobial Consumption in Hospitalized Patients with COVID-19
title_full_unstemmed An Ocean between the Waves: Trends in Antimicrobial Consumption in Hospitalized Patients with COVID-19
title_short An Ocean between the Waves: Trends in Antimicrobial Consumption in Hospitalized Patients with COVID-19
title_sort ocean between the waves trends in antimicrobial consumption in hospitalized patients with covid 19
topic COVID-19
antibiotic
pandemic
stewardship
url https://www.mdpi.com/2079-6382/13/1/55
work_keys_str_mv AT xavierduramiralles anoceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19
AT gabrielaabelendaalonso anoceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19
AT albabergas anoceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19
AT julialaporteamargos anoceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19
AT enricsastreescola anoceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19
AT ariadnapadulles anoceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19
AT jordicarratala anoceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19
AT carlotagudiol anoceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19
AT xavierduramiralles oceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19
AT gabrielaabelendaalonso oceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19
AT albabergas oceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19
AT julialaporteamargos oceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19
AT enricsastreescola oceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19
AT ariadnapadulles oceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19
AT jordicarratala oceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19
AT carlotagudiol oceanbetweenthewavestrendsinantimicrobialconsumptioninhospitalizedpatientswithcovid19